Provenienza dei contatti di primo grado di Sumio Ito
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Meltin MMI KK
Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan.
3
| Holding Company | Medical Specialties | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sumio Ito tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Financial Services Agency | General Government | Corporate Officer/Principal | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Hiroshima University | College/University | Doctorate Degree | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 4 |
Stati Uniti | 4 |
Regno Unito | 3 |
Settori
Health Technology | 7 |
Government | 2 |
Consumer Services | 2 |
Posizioni
Director/Board Member | 7 |
Corporate Officer/Principal | 2 |
Founder | 2 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Contatti più connessi
Insiders | |
---|---|
Shigeyuki Nishinaka | 9 |
Tatsuya Seki | 1 |
Masahiro Kasuya | 1 |
- Borsa valori
- Insiders
- Sumio Ito
- Connessioni Società